To evaluate the safety and efficacy of intravitreal conbercept after vitrectomy for the
management of early-stage proliferative diabetic retinopathy (PDR).
Hypothesis: intravitreal conbercept therapy may promote functional and anatomic recovery from
PDR. intravitreal conbercept therapy may be a useful and safe method for improving visual
outcomes of surgery for early-stage PDR.